Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05330767 · ClinicalTrials.gov registry record
DermaClose DUKE Fasciotomy and Wound Study
A clinical trial, sponsored by Baxter Healthcare Corporation.
- Terminated
- Registry status
- 7
- Enrollment target
NCT05330767 is a clinical trial that was terminated before completion, run by Baxter Healthcare Corporation. The registered enrollment target is 7 participants.
The verdict
NCT05330767 was terminated before completion, sponsored by Baxter Healthcare Corporation.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
To evaluate the clinical performance of DermaClose and DermaClose XL Continuous External Tissue Expander (CETE) devices to reduce wound size and/or assist with closure in acute full thickness wounds of the skin and assess the need for skin grafting for patients undergoing a four-compartment leg fasciotomy.
Interventions
- DEVICE DermaClose Continuous External Tissue Expander Device
- DEVICE DermaClose XL Continuous External Tissue Expander Device
- DEVICE Conventional wound dressings
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2022-08-22 |
| Est. Completion | 2023-11-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05330767
The ClinicalTrials.gov registry entry for NCT05330767 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baxter Healthcare Corporation, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which DermaClose Continuous External Tissue Expander Device is the first listed.
NCT05330767 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05330767 about?
NCT05330767 is a clinical study titled "DermaClose DUKE Fasciotomy and Wound Study". To evaluate the clinical performance of DermaClose and DermaClose XL Continuous External Tissue Expander (CETE) devices to reduce wound size and/or assist with closure in acute full thickness wounds of the skin and assess the need for skin grafting for patients undergoing a four-compartment leg fasc...
What is the current status of trial NCT05330767?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2022-08-22. Estimated completion is 2023-11-13.
What interventions are being tested in trial NCT05330767?
The interventions under investigation include: DermaClose Continuous External Tissue Expander Device (DEVICE), DermaClose XL Continuous External Tissue Expander Device (DEVICE), Conventional wound dressings (DEVICE).
Who is sponsoring clinical trial NCT05330767?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.